Are you part of the 1 in 10 adults that suffer from eczema or the 1 in 30 adults who suffer from psoriasis? Serious skin conditions can have a significant impact on your quality of life.
There is new help from what may seem like an unlikely source: cannabinoid ingredients from the cannabis plant.
Recent research reveals that cannabinoid receptors in the skin are involved in helping regulate skin cell growth, proliferation and overall skin health. Endocannabinoids and cannabinoid receptors are also known to mediate and inhibit inflammation in immune cells, nerve cells and skin cells themselves. Specifically, CBD (cannabidiol) has shown to enhance the activity of antioxidants and decrease the production of inflammatory markers in the skin, as well as increase levels of endocannabinoids and other mediators involved in wound healing. CBD is playing an increasing role in managing skin disorders such as psoriasis and eczema for many. People who suffer from these conditions are turning to CBD preparations as an alternative to or in conjunction with other topical remedies (such as topical hydrocortisone and other steroid preparations).
CBD is one of the main active cannabinoid compounds from cannabis and unlike THC, CBD does NOT cause a euphoric high, change motor function, or cause drowsiness.
Opticann’s new CB4 Derma Topical Soothing Cream is specially formulated with colloidal oatmeal, known to soothe inflamed and irritated skin and is designed to deliver CBD into the dermis to maximize its effect. Unlike other topical CBD products, CB4 Derma is clinically tested and proven to effectively deliver CBD to the site of action for improving skin hydration and reducing erythema (redness of the skin).
All Opticann CB4 products are developed with innovative pharmaceutical technology and are scientifically tested to provide maximum benefits, quickly. Register to become a patient and get a free medical consultation to get access to CB4 products (all products require a Medical Document from a prescriber).